Tikvah Management LLC Buys 2, Sells 3 in 4th Quarter

Tikvah Management LLC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

831 E. Morehead Street, Suite 940 Charlotte, NC 28202

As of the latest 13F report, the guru’s equity portfolio contained 23 stocks valued at a total of $209.00Mil. The top holdings were BIO(19.48%), AMZN(14.14%), and AVDX(13.06%).

According to GuruFocus data, these were Tikvah Management LLC’s top five trades of the quarter.

Procore Technologies Inc


The guru established a new position worth 194,600 shares in NYSE:PCOR, giving the stock a 4.38% weight in the equity portfolio. Shares traded for an average price of $51.06 during the quarter.

On 02/07/2023, Procore Technologies Inc traded for a price of $58 per share and a market cap of $8.00Bil. The stock has returned -7.35% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 1 out of 10.

In terms of valuation, Procore Technologies Inc has a price-book ratio of 7.12, a EV-to-Ebitda ratio of -33.41 and a price-sales ratio of 11.81.

Benefitfocus Inc


The guru sold out of their 975,118-share investment in NAS:BNFT. Previously, the stock had a 2.86% weight in the equity portfolio. Shares traded for an average price of $8.98 during the quarter.

On 02/07/2023, Benefitfocus Inc traded for a price of $10.5 per share and a market cap of $362.03Mil. The stock has returned 2.54% over the past year.

GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 2 out of 10.

In terms of valuation, Benefitfocus Inc has a EV-to-Ebitda ratio of 34.23 and a price-sales ratio of 1.42.

The price-to-GF Value ratio is 1.06, earning the stock a GF Value rank of 5.

Amazon.com Inc


Tikvah Management LLC reduced their investment in NAS:AMZN by 23,000 shares. The trade had a 1.2% impact on the equity portfolio. During the quarter, the stock traded for an average price of $98.78.

On 02/07/2023, Amazon.com Inc traded for a price of $102.18 per share and a market cap of $1,047.07Bil. The stock has returned -35.18% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Amazon.com Inc has a price-book ratio of 7.17, a EV-to-Ebitda ratio of 29.45 and a price-sales ratio of 2.03.

The price-to-GF Value ratio is 0.52, earning the stock a GF Value rank of 4.

Singular Genomics Systems Inc


Tikvah Management LLC reduced their investment in NAS:OMIC by 1,000,000 shares. The trade had a 1.15% impact on the equity portfolio. During the quarter, the stock traded for an average price of $2.23.

On 02/07/2023, Singular Genomics Systems Inc traded for a price of $2.95 per share and a market cap of $210.62Mil. The stock has returned -64.71% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 1 out of 10.

In terms of valuation, Singular Genomics Systems Inc has a price-book ratio of 0.76 and a EV-to-Ebitda ratio of -0.07.

SomaLogic Inc


During the quarter, Tikvah Management LLC bought 830,000 shares of NAS:SLGC for a total holding of 4,214,740. The trade had a 0.99% impact on the equity portfolio. During the quarter, the stock traded for an average price of $2.79.

On 02/07/2023, SomaLogic Inc traded for a price of $3.53 per share and a market cap of $661.97Mil. The stock has returned -59.56% over the past year.

GuruFocus gives the company a financial strength rating of 10 out of 10 and a profitability rating of 1 out of 10.

In terms of valuation, SomaLogic Inc has a price-book ratio of 1.10, a EV-to-Ebitda ratio of -6.31 and a price-sales ratio of 6.39.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.